Paradoxical high-density lipoprotein reduction induced by fibrate therapy.
Oleesky
D A
DA
Mir
M A
MA
D000328:Adult; D001629:Bezafibrate / Q000627:therapeutic use*; D008076:Cholesterol, HDL / Q000097:blood* / Q000187:drug effects; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D008297:Male; D011719:Pyrazines / Q000627:therapeutic use
D008076:Cholesterol, HDL; D000960:Hypolipidemic Agents; D011719:Pyrazines; C027696:acipimox; D001629:Bezafibrate